The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers, 2005Reduction of NURR1 mRNA in Human Peripheral Blood Lymphocytes as a Biomarker of PD
Parkinson's disease is a common neurodegenerative disease in adults, affecting over 1 million people in the United States. The neuropathology in the brain has been progressing long before the clinical...
-
MJFF Research Grant, 2012Analysis of Archived Tissue from Parkin, DJ-1, PINK1 and LRRK2 KO Pre-Clinical Models
Objective/Rationale:
As part of a broad effort to develop preclinical models of Parkinson’s disease (PD), MJFF sponsored the generation and initial characterization of knockout pre...
-
Target Validation, 2013Effects of IL-10 on Neurodegeneration in Mutant Alpha-Synuclein Transgenic Models
Objective/Rationale:
One of the hallmark pathologies in the brains of patients with Parkinson’s disease (PD) is an inflammatory response. We will test whether the cytokine interleukin-10... -
MJFF Research Grant, 2013Development of G2019S Selective LRRK2 Inhibitors for the Treatment of Parkinson’s Disease
Objective/Rationale:
The LRRK2 kinase has been implicated as a potential therapeutic target for the treatment of Parkinson’s disease (PD). The goal of this project is to make experimental... -
Rapid Response Innovation Awards, 2013Evaluation of Targeted Plasticity Therapy as a Treatment for Motor Dysfunction in Parkinson’s Disease
Objective/Rationale:
Deterioration of motor function is a debilitating symptom of Parkinson’s disease (PD). We have recently developed a novel method that utilizes stimulation of the...
-
MJFF Research Grant, 2013Specific Modulation of Tau Oligomers by Passive Immunotherapy in a Parkinson's Disease Model
Objective/Rationale:
The accumulation of tau protein is an important pathogenic factor in Parkinson’s disease (PD) and other neurodegenerative disorders. Our recent findings from pre-clinical models...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.